Notably, lncRNA breast cancer antiestrogen resistance 4 (BCAR4) has been proven to regulate the proliferation, stemness, and metastasis of various types of cancer, including breast cancer (BC), colorectal cancer (CC) and non-small cell lung cancer (NSCLC). Here, BCAR4 is linked to non-small cell lung carcinoma.